A PLACEBO-CONTROLLED DOUBLE-BLIND-STUDY OF EPALRESTAT (ONO-2235) IN PATIENTS WITH DIABETIC NEUROPATHY

被引:20
|
作者
GOTO, Y [1 ]
HOTTA, N [1 ]
SHIGETA, Y [1 ]
SAKAMOTO, N [1 ]
KITO, S [1 ]
MATSUOKA, K [1 ]
TAKAHASHI, A [1 ]
KIKKAWA, R [1 ]
SAKUMA, A [1 ]
机构
[1] NAGOYA UNIV,SCH MED,DEPT INTERNAL MED 3,65 TSURUMAI CHO,SHOWA KU,NAGOYA,AICHI 466,JAPAN
关键词
ALDOSE REDUCTASE INHIBITOR; CLINICAL TRIALS; DIABETIC NEUROPATHY; EPALRESTAT; HEMOGLOBIN A1C; NERVE CONDUCTION VELOCITY;
D O I
10.1111/j.1464-5491.1993.tb00197.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:S39 / S43
页数:5
相关论文
共 50 条